Dendritic cell-based immunotherapy in ovarian cancer

Por Coosemans, An, Vergote, Ignace, Van Gool, Stefaan W
Publicado em 2013

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells

Por Jacobs, Sandra A, Roobrouck, Valerie D, Verfaillie, Catherine M, Van Gool, Stefaan W
Publicado em 2013

Dendritic cell immunotherapy in uterine cancer

Por Coosemans, An, Tuyaerts, Sandra, Vanderstraeten, Anke, Vergote, Ignace, Amant, Frédéric, Van Gool, Stefaan W
Publicado em 2014

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?

Por Koks, Carolien A.E., De Vleeschouwer, Steven, Graf, Norbert, Van Gool, Stefaan W.
Publicado no J Cancer (2015)

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

Por Vandenberk, Lien, Belmans, Jochen, Van Woensel, Matthias, Riva, Matteo, Van Gool, Stefaan W.
Publicado no Front Immunol (2016)

Primed tumor-reactive multifunctional CD62L(+) human CD8(+)T-cells for immunotherapy

Por Wölfl, Matthias, Merker, Katharina, Morbach, Henner, Van Gool, Stefaan W., Eyrich, Matthias, Greenberg, Philip D., Schlegel, Paul G.
Publicado em 2010

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma

Por Maes, Wim, Rosas, Georgina Galicia, Verbinnen, Bert, Boon, Louis, De Vleeschouwer, Steven, Ceuppens, Jan L., Van Gool, Stefaan W.
Publicado em 2009

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Por van Woensel, Matthias, Wauthoz, Nathalie, Rosière, Rémi, Amighi, Karim, Mathieu, Véronique, Lefranc, Florence, van Gool, Stefaan W., de Vleeschouwer, Steven
Publicado em 2013

Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients

Por Ion-Margineanu, Adrian, Van Cauter, Sofie, Sima, Diana M., Maes, Frederik, Van Gool, Stefaan W., Sunaert, Stefan, Himmelreich, Uwe, Van Huffel, Sabine
Publicado no Biomed Res Int (2015)

Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma

Por Vandenberk, Lien, Garg, Abhishek D., Verschuere, Tina, Koks, Carolien, Belmans, Jochen, Beullens, Monique, Agostinis, Patrizia, De Vleeschouwer, Steven, Van Gool, Stefaan W.
Publicado no Oncoimmunology (2015)

Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8(+) Cytotoxic T Lymphocytes

Por Plessers, Jeroen, Dekimpe, Emily, Van Woensel, Matthias, Roobrouck, Valerie D., Bullens, Dominique M., Pinxteren, Jef, Verfaillie, Catherine M., Van Gool, Stefaan W.
Publicado no Stem Cells Transl Med (2016)